SoftMedx Healthcare Limited released its monthly return for the period ending 30 April 2026, detailing an issuance of 16.30 million ordinary shares during the month.
At the start of April, SoftMedx had 2.13 billion ordinary shares in issue. The additional allotment lifted the total to 2.14 billion shares, marking a 0.77% month-on-month increase. The company reported no treasury shares on its balance sheet, indicating that all issued shares are outstanding.
SoftMedx confirmed that it continues to meet the Hong Kong Stock Exchange’s minimum public-float requirement of 25% of issued shares.
The filing notes no activity under share option schemes, warrants, convertibles, or other equity-linked instruments during the month.
The return was signed by Company Secretary Lam Sung Him Gaston on 4 May 2026.